Monday, August 3, 2009
Impact of Indian Trade Agreement
Professor Lee Branstetter and graduate student Chirantan Chatterjee, in ongoing research funded by the Alfred P. Sloan Foundation, have been exploring how fundamental trade and intellectual property rights reform have transformed the Indian pharmaceutical and biotechnology industries.
Some Indian industry leaders and their advocates in government asserted that the creation of patent protection in India would force up prices for essential medicines without generating any positive benefit in the form of increased R&D and innovation, either on the part of domestic firms or through multinational firms shifting R&D to India.
Instead, the pair identified a relationship between the implementation of the patent policy and a rise in research investment and industry growth.
Chatterjee will continue to explore these issues in the coming year as part of his doctoral dissertation.